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Objective To determine whether Escherichia coli strains isolated from patients with uncomplicated
acute pyelonephritis can be distinguished from those isolated from patients with complicated acute
pyelonephritis on the basis of the genetic background.
Methods In total, 103 E. coli strains isolated from patients with acute pyelonephritis (59 uncomplicated
pyelonephritis (UAP) and 44 complicated pyelonephritis (CAP)) were characterized by RFLP of the
intergenic spacer region 16S23S rRNA, the presence of three alternative sequences found in the
polymorphic V6 loop of the 16S rRNA gene, the presence of the pap gene, and antibiotic
susceptibility.
Results At similarity levels of 70%, four RFLP groups (a1, a2, b1 and b2) were discerned. Strains from UAP
were statistically significant for a RFLP, with a strong association with the presence of the pap gene, V6-I
sequence and antibiotic multisensitivity. Strains from CAP randomly belonged to the a or b RFLP groups,
with a very low presence of the pap gene, and random presence of V6 sequences, and were multiresistant
to antibiotics. When the CAP strains were distributed according to underlying pathology, non-obstructive
cases had RFLP and V6 polymorphisms similar to those of UAP cases, while obstructive cases were
clearly distinct.
Conclusions UAP and non-obstructive CAP E. coli strains are sensitive to antimicrobials, show a high level of
the pap gene and belong to the selective, homogeneous and highly protected molecular a2 group, where no
recombinations, deletions or insertions are present. On the contrary, obstructive and vesicorenal reflux E. coli
strains show significant antimicrobial resistance, high intercistronic heterogenicity (wide presence of block
nucleotidic substitutions, deletions or insertions) and significantly lower virulence.
Keywords Escherichia coli, 16S23S intergenic spacers, uncomplicated acute pyelonephritis, complicated
acute pyelonephritis, antibiotic susceptibility
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INTRODUCTION
It is well known that Escherichia coli is the most frequent etiologic
agent causing human urinary tract infections (UTIs) [1]. Viru-
lence factors have been associated with the ability to cause
UTI, especially uncomplicated pyelonephritis, in previously
healthy people. These virulence factors include P-fimbriae,
siderophores (aerobactin), a-hemolysins and necrocytotoxic
factors [2,3]. P-fimbriae are encoded by the pap gene and play
a major role in cubic epithelium adhesion. This bacterial
attachment is considered as indispensable in the development
of pyelonephitis.
Study of the phylogenetic relationships between pyelone-
phritogenic E. coli strains could improve our understanding of
pyelonephritis pathology. For this, one of the most powerful
tools is the comparison of homologous sequences coding the
ribosomal RNA. The rRNA multigene family of E. coli
comprises seven rrn operons of similar, but not identical,
sequences. Between the rRNA genes there are spacers contain-
ing one or more types of tRNA gene, target sequences for
RNase-III required for processing of the transcript, and DNA
of unknown function that is highly variable. The sequences of
the spacers have been considered as good fast molecular clocks
to measure major intraspecies lineages [4–7]. In a previous
study, the 16S23S rRNA intergenic spacer regions of uro-
pathogenic E. coli and ECOR reference strains were amplified
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and subjected to endonuclease digestions [4]. Analysis of restric-
tion fragment length patterns (RFLP) showed two markedly
different clusters, called a and b. Furthermore, a stem-loop
located within the 16S rRNA gene, at region V6 (positions
1000–1040), showed three different primary structures (V6-I,
V6-II, V6-III) based on 12 polymorphic sites; the presence or
absence of these polymorphisms was linked to phylogenetic
lineages within E. coli [8].
The aim of the work reported in this paper was to determine
whether E. coli strains isolated from patients with uncompli-
cated acute pyelonephritis (UAP) can be distinguished from
strains isolated from patients with complicated acute pyelone-
phritis (CAP) on the basis of the genetic background, as shown
by RFLP of the 16S23S rRNA spacer and the polymorphisms
affecting the V6 loop of the 16S rRNA gene. The presence of
the P-fimbriae gene and the resistance to antibiotics of the
strains were also determined as virulence factors involved in the
severity of the infection.
MATERIALS AND METHODS
Selection of patients and bacterial strains
Acute pyelonephritis diagnosis was achieved in patients with
urine containing >10 leukocytes/High Power Field (HPF), or
>45 leukocytes/mL and >104 CFU/mL, plus at least three of
the following clinical symptoms: high fever (>38 8C) (91%),
lumbar pain (97%), flank pain on palpation (97%) and lower
urinary tract symptoms (69.5%). Patients without previous
urologic disease were provisionally classified as as having
UAP. The UAP diagnoses were confirmed in patients with
normal renal ecography, clinical and bacteriological eradication
at 6 months and 1 year follow-ups. In any other cases, patients
were classified as having CAP.
For the study, 103 E. coli strains from urine cultures of
different patients were isolated. Diffusion (Rosco tablets)
susceptibility tests, following the NCCLS recommendations
(M2-A7) [9], to first- and second-generation cephalosporins
(cephalexin and cefonicid), amoxicillin, amoxicillin–clavulanate,
fluoroquinolones (norfloxacin, ciprofloxacin), aminoglycosides
(gentamicin), co-trimoxazole and fosfomycin were performed.
Strains were initially identified by indol and b-glucuronidase
tests, and stored at 40 8C until the day of assay.
DNA extraction
Bacterial colonies were harvested in 200mL of InstaGene-TM
Purification Matrix (BioRad, Hercules, CA) by centrifuga-
tion at 10 000 rev/min for 1 min in a Biofuge-13 (Heraeus
Spatech, Germany), and the resultant pellet was incubated at
56 8C for 20 min. The tube was vortexed at high speed for 10 s,
placed in a boiling water bath for 8 min, and vortexed again
at high speed for 10 s. After centrifugation at 12 000 rev/min
for 2 min, the supernatant was removed and stored at 20 8C.
DNA concentrations were spectrophotometrically estimated
with the GeneQuant RNA/DNA calculator (Pharmacia
LKB Biochrom, Cambridge, UK) in 0.5-mm-diameter quartz
capillaries. DNA dilutions of 20 ng/mL were used for PCR.
Oligonucleotide primers
The characteristics of primers for PCR and probes V6-I, V6-II,
AdOF and Ad10R are listed in Table 1. Oligonucleotides were
purchased from Pharmacia Biotech (Piscataway, NJ) and resus-
pended in sterile distilled water to a final concentration of
50 pmol/mL. Primers to amplify the pap gene were designed
from sequences conserved for the G adhesin classes II and III
and synthesized. V6-specific probes were designed from V6-I
and V6-II sequences and combined with universal primer
16S0F for PCR tests. In both cases, the result was considered
to be positive when the reaction yielded amplicons of 1000 bp.
PCR amplification
Approximately 40 ng of chromosomal DNA was subjected to
PCR amplification in a total volume of 50 mL containing 50 mM
KCl, 10 mM Tris-HCl (pH 9.0 at 25 8C), 1.5 mM MgCl2,
0.1% (v/v) Triton X-100, 0.2 mM each deoxyribonucleotide
(dATP, dCTP, dGTP, dTTP; Pharmacia LKB Biotechnology,
Piscataway, NJ), 2 U of TaqI DNA polymerase (Promega Corp.,
Table1 PCR primers used in this work
Code Target Sequence (50 . . .30) Position Reference
16SOF 16S rRNA gene AGAGTTTGATCATGGCTCAG 8^27 5
16S14F 16S rNA gene CTTGTACACACCGCCCGTC 1389^1407 5
23S1R 23S rRNA gene GGGTTTCCCCATTCGGAAATC 124^110 5
V6-I 16S rRNA gene ACATTCTCATCTCTGAAAAC 1025^1006 8
V6-II 16S rRNA gene ACCAATCCATCTCTGGAAAG 1025^1006 8
Ad0F papG CTGTAATTACGGAAGTGATTTCTG 1199^1207 4
Ad10R papG CACTATCCGGCTCCGGATAAACCAT 2255^2231 4
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Madison, WI) and 50–60 pmol of each primer (16S14F and
23SIR). The reaction mixtures were subjected to a thermal
cycling regime (35 cycles on a ‘Peltier-effect’ thermal cycler
PTC-100; MJ Research, Inc., Watertown, MA) of 94 8C for
30 s, 55 8C for 15 s and 72 8C for 2 min, and finally a single step
of 72 8C for 5 min. For probes V6-I and V6-II (combined with
16SOF primer), the same conditions were used except for
annealing steps of 64 8C and 67 8C, respectively. Annealing
for probes Ad0F and Ad10R was at 60 8C. Negative controls
with no addition of DNA template were included. PCR
products were precipitated, dried, and resuspended in 25mL
of sterile water. Following amplification, 5 mL of PCR products
was electrophoresed on 1% agarose gels in Trishacetatehedta
(TAE) buffer. The 1-kb DNA ladder (Gibco, BRL, Gaithers-
burg, MD) was used as molecular marker. Agarose gels were
stained with 0.5 mg/L of ethidium bromide per ml, visualized
with ultraviolet light (l312 nm), and photographed using Polar-
oid-type 665 films.
Endonuclease digestions and electrophoresis
PCR products were subjected to separate restriction reactions,
each with a single enzyme. Enzymatic digestions were per-
formed by incubating 8 mL of the amplification products with
5 U of each of the enzymes RsaI and TaqI in a final volume of
20 mL. The reaction mixture was incubated overnight at 37 8C.
Aliquots of 10 mL of each restriction reaction mixture were
mixed with 2mL of loading buffer (0.25% bromophenol blue,
0.25% xylene-cyanol, 30% glycerol), and electrophoresed on
4% Metaphor agarose gel (FMC BioProducts, Rockland, MN)
in 0.5  TBE (Tris-Borate-EDTA) buffer. The 1-kb DNA
ladder (Gibco, BRL) was used as molecular marker. Gels were
stained with ethidium bromide and photographed using a UV
transilluminator.
RFLP pattern analysis
RFLP profiles were analyzed by eye, and data converted to two-
dimensional binary matrices with the following criteria: 1 if a
band was present, and 0 if a band was absent. The NTSYS-pc
program (version 8, Exeter Software, Setauket, NY) converted
the bidimensional matrices into symmetric matrices by com-
parison of strain couples.
Statistical analysis
To proportion comparisons, Chi-square and exact Fisher’s tests
were performed. A logistic regression method was applied to
measure the risk association of UAP versus CAP in respect of
the following variables: type of group, presence or absence
of the pap gene, type of V6 sequence, and susceptibility to
antibiotics.
RESULTS
16S23S rRNA spacer PCR-RFLP polymorphisms
In total, 15 RFLP fragments were identified, nine bands with
RsaI (molecular size of 160, 220, 340, 410, 520, 600, 630, 800
and 900 bp), and six bands with TaqI (molecular size of 340,
400, 570, 630, 650 and 800 bp) (Figure 1). Based on the
presence or absence of the bands, a similarity matrix was
generated and the strains clustered accordingly. At similarity
levels over 50%, the strains clustered in two large groups named
a and b. At similarity levels of 70%, four groups (a1, a2, b1, b2)
were discerned. It was observed that membership of the a or b
groups depended on the polymorphisms generated by RsaI,
while membership of the subgroups depended on the poly-
morphisms generated by TaqI.
Distribution of the pap gene andV6 sequences in the different
molecular groups according to clinical diagnosis
V6 sequence polymorphism found in the 16S rRNA gene was
distributed as follows: 59.2% V6-I, 37.8% V6-IþV6-II, and
the rest V6-II. In the UAP group (59 cases: three men and 56
women) (age d-1: 35 16 years, range 17–85), the frequency
of strains belonging to the a group reached 78% (P¼ 0.007)
(74% in the a2 subgroup with 91.2% of V6-I sequence, and 26%
in the a1 subgroup with 42% V6-I and 50% V6-IþV6-II
sequences). The frequency of the pap gene was very high in
both cases (85.3% and 83.3%, respectively). Strains belonging to
the b group also showed, in both subgroups, higher frequencies
of the pap gene (67–80%) and a high frequency (79%) of the
V6-IþV6-II sequence.
In the CAP group (44 cases: 29 lithiasis, 11 vesicorenal
reflux and four others) (seven male and 37 female) (age
d-1: 44 20 years, range 9–78), the frequency of strains belong-
ing to the a or b groups was random (NS). The frequency of the
pap gene clearly decreased (in the b group especially) with
respect to the UAC group (P< 0.001) (Table 2). The V6
sequences were distributed as follows: 95% of V6-I for the
a2 subgroup, 28.5% of V6-I/28.5% of V6-II/43% of
V6-IþV6-II for the a1 subgroup, and 87.5% of V6-IþV6-II
for the b group.
Additional data on strain virulence were obtained when CAP
cases were subdivided, according to underlying disease, into
non-obstructive pathology (13 cases), obstructive pathology (20
cases), and vesicorenal reflux (11 cases). In non-obstructive
cases, a very closed molecular structure for UAP cases (NS)
(a group: 76.9%, high frequency of pap gene (84.6%) and V6-I
structure (69.2%)) was observed. On the contrary, for the rest of
the cases (obstructive pathologyþ vesicorenal reflux), the allo-
cations to a or b groups and V6 structure type were random
(NS), and the pap gene frequency was very low (12.9%)
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(P< 0.001)(Table 3). The sum of UAPþ non-obstructive CAP
(72 strains) was significant (P< 0.01), with respect to obstruc-
tive/reflux CAP cases (31 strains), for pap gene frequency,
a group and V6-I sequence.
Molecular groups and resistance to antimicrobial agents
Globally (Table 4), the pap gene is less frequent in multiresistant
strains than in sensitive or monoresistant strains (33% versus
73%). When the data are distributed according to the spacer
RFLP groups, the incidence of multiresistant strains in group a
is clearly lower than in group b (5.6% versus 25%, respectively)
(P< 0.01). However, when multiresistant strains in group a
(four strains) were observed, they showed nearly the same
frequency of pap gene presence as sensitive strains. On the
contrary, in the b group multiresistant strains, the pap gene
frequency (12.5%) was more than four times lower than in
sensitive strains (56–67%) (P< 0.01).
The difference between the sets ‘strains from UAPþ a
groupþ pap gene presenceþV6-I structureþmultisensitivity’
and ‘strains from CAPþ b groupþ pap gene absenceþ other
than V6-I structureþmultiresistance’ was highly significant
(P< 0.001) (OR¼ 0.1 (0.04–0.26) in the multivariate
analysis.
Table 2 Molecular characteristics of uncomplicated acute pyelonephritis
and complicated acute pyelonephritis
papþ V6-I V6-II V6-IþV6-II
UAP (59)
a group
46 (78%)
a1 (12) 10 (83.3%) 5 1 6
a2 (34) 29 (85.3%) 31 0 3
b group
13 (22%)
b1 (3) 2 (67%) 1 0 2
b2 (10) 8 (80%) 0 0 10
Statistics a/b
<0.01 NS <0.001
CAP (44)
a group
28 (63.6%)
a1 (7) 4 (57%) 2 2 3
a2 (21) 8 (47.6%) 20 0 1
b group
16 (36.4%)
b1 (10) 1 (10%) 1 0 9
b2 (6) 1 (16.7%) 1 0 5
Statistics a/b
NS <0.01 <0.01
Table 3 Underlying urologic diseases in complicated pyelonephritis and strainmolecular pattern
No. papþ a1 a2 b1 b2 V6-I V6-II V6-1þV6-II
Non-obstructive pathologya 13 11 2 8 2 1 9 0 4
Obstructive pathologyb 20 3 4 6 4 6 9 2 9
Vesicorenal refluxc 11 1 1 4 3 3 5 1 5
Stastics NOP versus OPþ VRR<0.005 <0.005 NS NS NS NS NS NS NS NS
aAll were lithiasis cases.
bIncluded:16 lithiasis, two congenital malformations, one renal transplant and one bladder tumor.
cAll were congenital malformations.
NOP, non-obstructive pathology; OP, obstructive pathology;VRR, vesicorenal reflux.
Table 4 Molecular groups and antimicrobial resistance
All strains a group b group
No. of strains/No. of papþ No. of strains/No. of papþ No. of strains/No. of papþ
Sensitives 33/24 (73%) 24/19 (79%) 9/5 (56%)
R¼ one antibiotic (AM/COT) 31/23 (74%) 25/19 (76%) 6/4 (67%)
R¼ two antibiotics (AMþCOT) 27/13 (48%) 18/11 (61%) 9/2 (22%)
R> three antibiotics
(AMþCOTþ FQþCF/GM)a
12/4 (33%) 4/3 (75%) 8/1 (12.5%)
aAmoxicillinþ co-trimoxazoleþ fluoquinolonesþ first- and second-generation cephalosporins and gentamicin.
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DISCUSSION
Previous studies have pointed out that bacteria need virulence
factors to invade the healthy urinary tract and kidneys of
immunocompetent subjects. Clinical experience indicates that
E. coli is the best adapted bacterium, because it is the most
frequent etiologic agent of UAP (>90%). A wide number of
studies [9–12] have established that P-fimbria expression is an
essential virulence factor for kidney invasion. In this sense,
studies with a non-adhesive fecal E. coli strain showed that the
addition of a plasmid encoding P-fimbria expression resulted in
the acquisition of adhesive properties for binding animal or
human renal tubular cells [13]. The concomitant presence of
other virulence factors potentially increases the renal invasive
ability [14–16].
There are approximately 50 000 different serotypes of E. coli,
but only 10 have been related to pyelonephritis and urosepsis.
They are considered as highly virulent strains, since they
can simultaneously express several virulence factors. Previous
studies using carboxylesterase B electrophoretic pattern
(MLEE) indicated that they belong to the B2 group [17–21].
In this group, DNA fragments (named ‘pathogenicity-
associated islands’ or PAIs) have been recently identified, in
or near [22] the tRNA genes, that encode P-fimbria, 1-fimbria,
a-hemolysin, aerobactin and necrocytotoxic factor synthesis
[23]. The presence of PAIs allows the bacteria to colonize
squamous, transitional and renal tubular epithelia, avoid
natural defense mechanisms, grow in adverse media, and pro-
voke internalization by means of toxic actions on the epithelial
cells.
Strains belonging to the a2 subgroup are closely related to the
MLEE method B2 group (data obtained by RFLP of 20
reference strains from the ECOR collection). Moreover, if
by PCR the V6-I structure is detected, the probability that
this strain belongs to the B2 group is empirically greater than
80%. On the other hand, V6-II structure detection (almost
always associated with V6-I) indicates a high probability that it
belongs to another group than B2. So, 93.7% of the b2 group
showed V6-IþV6-II structures and they are related to the D2
group of MLEE.
Globally assessed, the studied uropathogenic E. coli strains
seem to be more diverse than would be expected. However,
when UAPþ non-obstructive CAP cases are considered, the
molecular homogenicity characteristics significantly increased.
The classic denomination of pyelonephritogenic E. coli strains
now acquires a molecular sense, since the present work strongly
suggests that the most invasive E. coli strains (a2 group with
pap operon and V6-I sequence) are significantly isolated in
cases with complete defense mechanisms. They belong to an
elite group with a restricted molecular structure, with a
clearly homogeneous pattern, and with very high phylogenic
stability.
Figure 1 Agarose electrophoresis of PCR-RFLP16S23S spacers ofdiffer-
ent pyelonephritogenic E. coli strains, digested with RsaI (up) and TaqI
(down). Strains numbered 1, 5 and 9 belong to the a1subgroup (see text),
strains 4, 6, 7 and 8 to a2, and strains 2 and 3 to b2 (1^9). M¼1-kb ladder
(Gibco BRL) molecular marker (75^10180bp).
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In contrast, the molecular patterns in obstructive/reflux CAP
strains change, and, in this case, have high intercistronic hetero-
genicity. This means an increase of infective possibilities for
other types (including other bacterial species), which agrees
with accumulated clinical experience, where a non-selective
pyelonephritis etiology is observed [1]. An explanation for this
phenomenon could be that all underlying urologic pathologies
diminish or even annul the defense mechanisms, and the
consequence is that other non-virulent bacteria are able to
invade the urinary tract [24]. In fact, the power of underlying
disease to affect defense mechanisms could be evaluated accord-
ing to the pyelonephritis etiology. The present work shows that
vesicorenal reflux and obstructive pathology seriously affect the
defense mechanisms, since isolated strains show a non-mole-
cular selectivity (wide etiologic possibilities). Unexpectedly, this
work also reveals that non-obstructive foreign bodies (calculi)
do not affect the functionality and efficacy of defense mechan-
isms, since the isolated strains belong to the same molecular
group as UAP cases (restrictive etiology). Two questions arise
with these data: should the classic clinical definition for UAP
and CAP be changed, and could they explain why the pyelone-
phritis frequency in obstructive lithiasis is higher than in non-
obstructive cases?
Antimicrobial multiresistance is mainly associated with E. coli
strains not encoding virulence factors. The hypothesis is
that the virulent strains can not metabolically support the
additional plasmid DNA encoding the resistance information,
and, in consequence, they are sensitive to antimicrobials
[17,20]. This study agrees with this idea, but with some caveats.
Strains of molecular group b clearly support the hypothesis, but
not strains of the a molecular group. When multiresistant a
group strains have been observed, the pap gene expression rate
is as high as that of sensitive strains. There is no doubt that
the observed strain number is low, necessitating the gathering
of more information. However, these data seem to again
suggest an extremely high virulence potential for the a
molecular group, which seems to be able both to synthesize
virulence factors and to support resistance DNA plasmid
overload.
To summarize, RFLP of the 16S23S spacer appears to be a
good and reproducible method of typing E. coli strains. Their
relationship with the pyelonephritis clinical modality reveals
important information about their pathophysiology. Both UAP
and non-obstructive CAP E. coli strains are sensitive to anti-
microbials, and they belong to a selective, homogeneous and
highly protected molecular group (no recombinations, dele-
tions or insertions are present), which is coincident with the
MLEE-B2 group carrying PAIs. In contrast, obstructive and
vesicorenal reflux E. coli strains show higher antimicrobial
resistance, high intercistronic heterogenicity (presence of block
nucleotidic substitutions, deletions or insertions) and a very low
pap gene frequency.
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